Citation Impact
Citing Papers
Spatial Distribution of Fibrosis Governs Fibrillation Wave Dynamics in the Posterior Left Atrium During Heart Failure
2007
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans
2006
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Defibrillation shock success estimation by a set of six parameters derived from the electrocardiogram
2004
Idiopathic pulmonary fibrosis
2017 Standout
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation
2007
The Expression Levels of Plasma micoRNAs in Atrial Fibrillation Patients
2012
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence
2005
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation Results of a prospective and controlled study
2003
Is atrial fibrillation an inflammatory disorder?
2005
Purinergic regulation of the immune system
2016
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Management of atrial fibrillation in patients with heart failure
2007
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
2006
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways
2003
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation
2012
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
2003
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation
2005
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Recent advances in the molecular pathophysiology of atrial fibrillation
2011
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Nonchannel drug targets in atrial fibrillation
2004
Epicardial adipose tissue and atrial fibrillation
2014
The fibrosis and atrial fibrillation: Is the transforming growth factor-β1 a candidate etiology of atrial fibrillation
2007
EMT: 2016
2016 Standout
Secondary prevention with folic acid: effects on clinical outcomes
2003
Electrical, contractile and structural remodeling during atrial fibrillation
2002 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation
2004
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
2005
Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity
2015
High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation
2005
The basics of epithelial-mesenchymal transition
2009 Standout
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
2005
Selective Induction of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Atrial and Ventricular Myocardium in Patients With Atrial Fibrillation
2006
Diminished Cardiac Fibrosis in Heart Failure is Associated with Altered Ventricular Arrhythmia Phenotype
2010
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Impact of Left Atrial Volume on Clinical Outcome in Organic Mitral Regurgitation
2010
Spironolactone Therapy is Associated with Reduced Ventricular Tachycardia Rate in Patients with Cardiomyopathy
2010
Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women
2001
Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions
2016
Antifibrotic activities of pirfenidone in animal models
2011
Structural and Functional Remodeling of the Left Atrium
2008
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation
2008
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Noninvasive Characterization of Epicardial Activation in Humans With Diverse Atrial Fibrillation Patterns
2010
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure
2001
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease
2005
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans
2004
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Atrial Remodeling and Atrial Fibrillation
2008
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling
2007
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans
2005
Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat
2003
Works of Thomas H. Everett being referenced
Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure
2006
Effect of Electrical and Structural Remodeling on Spatiotemporal Organization in Acute and Persistent Atrial Fibrillation
2002
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling
2006
Basic mechanisms of atrial fibrillation
2004
Atrial fibrosis and the mechanisms of atrial fibrillation
2006
Concomitant SK current activation and sodium current inhibition cause J wave syndrome
2018
Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium
2004
Frequency domain algorithm for quantifying atrial fibrillation organization to increase defibrillation efficacy
2001
Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model
2013
Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation
2004
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation
2003
Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1
2004
Effects of the Gap Junction Modifier Rotigaptide (ZP123) on Atrial Conduction and Vulnerability to Atrial Fibrillation
2006
Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation
2000